Studies on the pathogenesis and early diagnosis of hepatocellular carcinoma

肝细胞癌（HCC）是最常见的原发性肝癌，在全球范围内分别是男性和女性癌症死亡的第三和第五大原因。早期诊断对患者的生存至关重要。我们的研究探索了早期诊断HCC的新方法，包括癌症的新蛋白标志物和肝瘢痕的非侵入性测量。我们还研究了HCC的遗传学，并研究了可能成为未来治疗靶点的新基因。

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and worldwide is the third and fifth leading cause of cancer death in men and women respectively. Early diagnosis is vital to patient survival. Our research investigates new methods in the early diagnosis of HCC, including new protein markers of the cancer and non-invasive measurements of liver scarring. We also study the genetics of HCC and investigate new genes that could be targets for future therapies.